You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 52 Next »

Project Scope 

This project team will create a users guide or White Paper with recommendations for analyses and displays associated with Hepatotoxicity, with a focus on Phase 2-4 clinical trials and integrated submission documents.

Project LeadsEmail

Melvin Munsaka (AbbVie)

melvin.munsaka@abbvie.com

Terry Walsh (Astellas

terry.walsh@astellas.com

Katie Warren (PHUSE Project Assistant)katie@phuse.global 

Objectives & Deliverables

Timelines 

Finalise stage 1 of draft White Paper for Public Review

Q2 2023

CURRENT STATUS Q1 2023

Working on a White Paper

Project MembersOrganisation
Amelia PangSanofi
Charles BeasleyMSN
Darshan Bhatt Industry 
Eileen Navarro AlmarioFDA
Hongli LuMerck
John Landry Eli Lilly
John MarciankAbbVie
Patrick HannonMMS 
Paul HayashiA2 Healthcare Corporation
Preeti VenkataramanFDA
ShayamiEli Lilly
Swarnalatha ReddyIndustry
Veronical Pei YangFDA
William Palo AbbVie
  • No labels